Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Piramal Pharma Share Price Gains Over 3% As US FDA Closes Inspection
With the closing of the inspection, strong buying interest has been witnessed in Piramal Pharma stock
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
Stocks to buy: Piramal Pharma, HSCL among 3 top bets by Choice Broking
Stocks to buy: Here's why Aakash Shah, technical analyst at Choice Broking recommends a 'Buy' on Piramal, Aza Engineering and Himadri Speciality Chemical this week.
Analysts back buy-on-dips strategy as Nifty targets 24,450–24,800
Indian stock market analysts are optimistic, anticipating the Nifty to continue its upward trend. They suggest buying on dips around the 24,000-24,150 mark, with potential upside targets reaching 24,800. Several stocks, including Container Corporation of India, IndusInd Bank, Biocon, HDFC Asset Management Company, Shriram Finance, and Piramal Pharma, are highlighted as strong buy recommendations with specific price targets and stop-losses.
BSE 500 stocks: Adani Ports, Marico, Ather, Piramal Finance hit new highs
Adani Enterprises, Aurobindo Pharma, GMR Airports, Gujarat Flurochemicals, Oracle Financial Services and Star Health Insurance from BSE 500 stocks registered 52-week highs on Wednesday.
Cohance Lifesciences Ltd leads gainers in 'A' group
Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.
Nifty Pharma extends rally, up 2%; Piramal Pharma, Laurus gain up to 10%
Analysts said that a combination of defensive buying, strong earnings visibility, export tailwinds, and sector rotation is driving the rally in pharma stocks.
Piramal Pharma Ltd drops for fifth straight session
Piramal Pharma Ltd is quoting at Rs 165.7, down 3.04% on the day as on 13:19 IST on the NSE. The stock jumped 2.13% in last one year as compared to a 4.38% slide in NIFTY and a 11.99% spurt in the Nifty Pharma index.
Q4 Results Highlights: CEAT profit jumps 144%; Go Digit General Insurance profit up 29%
Q4 Results LIVE Updates: It is an important day today with regards to results, as India's largest passenger car manufacturer, Maruti Suzuki India Ltd., and food delivery-to-quick commerce operator Eternal, will be reporting results today. Besides these, there are plenty of broader market names, such as Bandhan Bank, Sapphire Foods, Castrol India, CEAT, Star Health, Piramal Pharma, REC, Motherson Sumi Wiring, Sanofi India, Sanofi Consumer Health, Leela Palace Hotels and many others will be reporting their results today. Watch this space for all the LIVE updates.
Top Gainers & Losers on Mar 12: Piramal Pharma, Tejas Networks, Apollo Tyres, PG Electroplast among top losers
The Indian stock market extended its losses on March 12, with the Nifty 50 and Sensex down 1% and 1.08%. Tensions in the Middle East affected investor sentiment, particularly impacting auto stocks, while broader markets showed some positive movement.
Tejas Networks Ltd leads losers in 'A' group
Piramal Pharma Ltd, Northern ARC Capital Ltd, IndusInd Bank Ltd and Amber Enterprises India Ltd are among the other losers in the BSE's 'A' group today, 12 March 2026.
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.